Interventional
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Andreas Josting, Dr.
Principal Investigator
University of Cologne
Germany: Federal Institute for Drugs and Medical Devices
BACOPP-21
NCT00284271
January 2004
Name | Location |
---|